DV890

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DV890, covering 2021-11-30 to 2021-11-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia [Phase 2]